Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Generalized eruptive keratoacanthoma (GEKA) is rare variant of keratoacanthoma (KA) that affects the skin and mucous membranes and which is characterized by a sudden generalized eruption of severely pruritic, hundreds to thousands of small follicular papules, often with a central keratotic plug.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for generalized eruptive keratoacanthoma.
6 publications have been identified in PubMed for generalized eruptive keratoacanthoma. Research spans Case Report / Case Series (60%), Other (20%), and Review / Meta-Analysis (20%).
Kormos NF (2026). [PMID: 40932161](https://pubmed.ncbi.nlm.nih.gov/40932161/). *Int J Dermatol*. [Review / Meta-Analysis]
Creighton R (2025). [PMID: 41454524](https://pubmed.ncbi.nlm.nih.gov/41454524/). *J Cutan Med Surg*. [Other]
Li S (2025). [PMID: 40661116](https://pubmed.ncbi.nlm.nih.gov/40661116/). *JAAD Case Rep*. [Case Report / Case Series]
Arandjelovic A (2025). [PMID: 40036322](https://pubmed.ncbi.nlm.nih.gov/40036322/). *Clin Exp Dermatol*. [Case Report / Case Series]
Ilaria P (2024). [PMID: 39205234](https://pubmed.ncbi.nlm.nih.gov/39205234/). *Viruses*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:04 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center